Zingiber officinale Roscoe on reducing ischemia-reperfusion injury
Early Phase 1
- Conditions
- coronary artery disease.120-125
- Registration Number
- IRCT20180118038426N1
- Lead Sponsor
- Khoram-Abad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Having a stenosis of at least 70% in at least one coronary artery
Exclusion Criteria
Ginger consumption 6 months before Study-Ginger sensitivity and its compounds-Chest pain 48 hours before Angioplasty
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Troponin enzyme. Timepoint: 24 hours after angioplasty. Method of measurement: labratory kit.
- Secondary Outcome Measures
Name Time Method